$243 Million is the total value of Navalign, LLC's 126 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC | $6,277,968 | +16.5% | 23,903 | 0.0% | 2.59% | +6.7% | |
| LLY | LILLY ELI & CO | $756,191 | +13.2% | 2,067 | 0.0% | 0.31% | +3.7% | |
| ISRG | INTUITIVE SURGICAL INC | $477,630 | +41.7% | 1,800 | 0.0% | 0.20% | +29.6% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $474,046 | -41.8% | 75,365 | 0.0% | 0.20% | -46.7% | |
| NEE | NEXTERA ENERGY INC | $371,769 | +6.5% | 4,447 | 0.0% | 0.15% | -2.5% | |
| MA | MASTERCARD INCORPORATEDcl a | $285,834 | +22.2% | 822 | 0.0% | 0.12% | +12.4% | |
| PLANET LABS PBC | $48,581 | -20.4% | 11,168 | 0.0% | 0.02% | -25.9% | ||
| HYRE | HYRECAR INC | $6,486 | -53.7% | 15,298 | 0.0% | 0.00% | -50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 11 | Q3 2023 | 9.4% |
| SCHWAB STRATEGIC TR | 11 | Q3 2023 | 8.2% |
| SPDR SER TR | 11 | Q3 2023 | 5.8% |
| SPDR SER TR | 11 | Q3 2023 | 5.7% |
| VANGUARD INDEX FDS | 11 | Q3 2023 | 5.4% |
| VANGUARD WHITEHALL FDS | 11 | Q3 2023 | 5.4% |
| FLEXSHARES TR | 11 | Q3 2023 | 5.3% |
| ISHARES TR | 11 | Q3 2023 | 4.9% |
| AMGEN INC | 11 | Q3 2023 | 2.6% |
| VANGUARD BD INDEX FDS | 11 | Q3 2023 | 3.4% |
View Navalign, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-01-18 |
| 13F-HR | 2023-10-11 |
| 13F-HR | 2023-07-14 |
| 13F-HR | 2023-04-20 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-07-27 |
| 13F-HR | 2022-04-29 |
| 13F-HR | 2022-02-08 |
View Navalign, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.